Toronto-based Titan Medical has received an $8.3 million payment from Medtronic for hitting the final milestone under their development and license agreement and has retired the senior secured loan from the medtech giant.
Spinal Tech
Surgeons are accustomed, in various degrees, to identifying a plan of action for their surgeries. However, there has never been a way to three-dimensionally represent the plan in the OR, until now. Becker’s Spine Review spoke with Christopher Kleck, M.D., an orthopedic spine surgeon and co-director of the spine fellowship program…
Zimmer Biomet files forms for ZimVie and six more key updates from spine and orthopedic device companies in the last week:
Five-year data on the Barricaid spinal implant shows it's effective in preventing reherniation and reoperation following lumbar discectomy.
Hyalex Orthopedics named two leadership appointments: CEO and chief technical officer.
A federal judge on Jan. 24 rejected Johnson & Johnson and subsidiary DePuy Orthopaedics' bid to make two orthopedic surgeons pay $2.4 million after their whistleblower case related to the company's Pinnacle hip implant portfolio was tossed.
Stryker has initiated a cash tender offer to purchase all outstanding shares of common stock of Vocera Communications for $79.25 per share in cash, the company said Jan. 25.
Sebastian Koga, MD, a neurosurgeon in Covington, La., completed the first cases with Aurora Spine's Apollo cervical plate.
Johnson & Johnson orthopedic sales in the U.S. and worldwide decreased year over year in the fourth quarter of 2021, according to financial results posted Jan. 25.
Medtronic's Intellis rechargeable neurostimulator and Vanta recharge-free neurostimulator were approved by the FDA for treating chronic pain associated with diabetic peripheral neuropathy.
